 |
|
 |
|
|
MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs for the prevention and treatment of major medical diseases and certain conditions with unmet medical need. With its expertise and experience in product development, the Company is focused on advancing its pipeline of product candidates in the areas of infectious and degenerative diseases. MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. |
||
|
Corporate Presentation BioFinance May 07, 2008 Click Here for Presentation
Third Quarter Fiscal 2008 Financial Results March 13, 2008
Second Quarter Fiscal 2008 Financial Results December 13, 2007 Click Here for Webcast (TRANSCRIPT)
Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference Click Here for Webcast November 5, 2007
UBS 2007 Global Life Sciences Conference September 27, 2007 Click Here for Webcast Click Here for Presentation
First Quarter Fiscal 2008 Financial Results September 11, 2007 Click Here for Webcast (TRANSCRIPT)
14th International Symposium on Hepatitis C Virus and Related Viruses September 9-13, 2007 Click Here for Poster Click Here for Abstract
2007 Annual Report (PDF)
|
|
Tuesday, May 06, 2008(PDF) - Omigard™ Phase III Pivotal Registration Study Enrollment Completed
Monday, April 21, 2008(PDF) - MIGENIX Appoints Pieter Dorsman to Board of Directors
Thursday, March 13, 2008(PDF) - MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
Tuesday, March 11, 2008(PDF) - MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Friday, February 15, 2008(PDF) - MIGENIX Releases CEO Message #22 Click Here for CEO Message
Thursday, January 31, 2008(PDF) - MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
Thursday, December 13, 2007(PDF) - MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
Monday, December 3, 2007(PDF) - MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study Four-Week Interim Results
Friday, November 30, 2007(PDF) - MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Wednesday, October 31, 2007(PDF) - MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Wednesday, October 17, 2007(PDF) - Omiganan Phase II Rosacea Study Demonstrates Promising Results, Partner Plans to Advance to Phase III
|
